Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
Yapeng LiXueying ZhengDongsheng TuJames N InglePaul E GossWendy R ParulekarGuoyou QinPublished in: Breast cancer research and treatment (2021)
NCT00754845.